ASKA Pharmaceutical Holdings Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3119660003
JPY
2,400.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
17,612.00
17,641.00
14,213.00
17,555.00
16,019.00
16,352.00
14,019.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
17,612.00
17,641.00
14,213.00
17,555.00
16,019.00
16,352.00
14,019.00
Raw Material Cost
9,255.00
9,012.00
7,335.00
9,005.00
8,282.00
8,181.00
6,985.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
58.00
51.00
16.00
13.00
11.00
11.00
9.00
Selling and Distribution Expenses
5,347.00
5,285.00
4,685.00
4,819.00
4,707.00
4,761.00
4,761.00
Other Expenses
178.00
181.40
234.00
156.90
143.00
164.10
129.00
Total Expenditure (Excl Depreciation)
16,440.00
16,162.00
14,376.00
15,406.00
14,430.00
14,594.00
13,045.00
Operating Profit (PBDIT) excl Other Income
1172
1479
-163
2149
1589
1758
974
Other Income
-71.00
288.00
1,225.00
-3.00
-77.00
67.00
379.00
Operating Profit (PBDIT)
1,872.00
2,351.00
1,654.00
2,732.00
2,082.00
2,324.00
1,924.00
Interest
58.00
51.00
16.00
13.00
11.00
11.00
9.00
Exceptional Items
0.00
0.00
-300.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
8,357.00
8,629.00
6,878.00
8,550.00
7,737.00
8,171.00
7,034.00
Depreciation
771.00
584.00
592.00
586.00
570.00
499.00
571.00
Profit Before Tax
1,040.00
1,716.00
746.00
2,134.00
1,499.00
1,813.00
1,342.00
Tax
2.00
372.00
-257.00
596.00
213.00
539.00
254.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
982.00
1,245.00
1,003.00
1,538.00
1,287.00
1,273.00
1,087.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
982.00
1,245.00
1,003.00
1,538.00
1,287.00
1,273.00
1,087.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
56.00
99.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,038.00
1,344.00
1,003.00
1,538.00
1,287.00
1,273.00
1,087.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
66,857.00
65,440.00
65,310.00
65,191.00
64,192.00
63,329.00
61,930.00
Earnings per share (EPS)
34.6
43.86
35.36
54.22
45.41
44.94
38.37
Diluted Earnings per share
34.6
43.86
35.36
54.22
45.41
44.94
38.37
Operating Profit Margin (Excl OI)
6.65%
8.38%
-1.15%
12.24%
9.92%
10.75%
6.95%
Gross Profit Margin
10.28%
13.04%
9.41%
15.49%
12.92%
14.14%
13.65%
PAT Margin
5.58%
7.06%
7.06%
8.76%
8.03%
7.78%
7.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 9.94% vs 2.52% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is -19.35% vs -52.35% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -10.00% vs 5.37% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 427.27% vs 10.00% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Compare Quarterly Results Of ASKA Pharmaceutical Holdings Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
17,612.00
9,500.00
8,112.00
85.39%
Other Operating Income
0.00
0.00
0.00
Total Operating income
17,612.00
9,500.00
8,112.00
85.39%
Raw Material Cost
9,255.00
5,812.00
3,443.00
59.24%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
58.00
34.00
24.00
70.59%
Selling and Distribution Expenses
5,347.00
2,227.00
3,120.00
140.10%
Other Expenses
178.00
-3.40
181.40
5,335.29%
Total Expenditure (Excl Depreciation)
16,440.00
8,039.00
8,401.00
104.50%
Operating Profit (PBDIT) excl Other Income
1,172.00
1,461.00
-289.00
-19.78%
Other Income
-71.00
1,713.00
-1,784.00
-104.14%
Operating Profit (PBDIT)
1,872.00
3,835.00
-1,963.00
-51.19%
Interest
58.00
34.00
24.00
70.59%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
8,357.00
3,688.00
4,669.00
126.60%
Depreciation
771.00
661.00
110.00
16.64%
Profit Before Tax
1,040.00
3,140.00
-2,100.00
-66.88%
Tax
2.00
916.00
-914.00
-99.78%
Provisions and contingencies
0
0
0.00
Profit After Tax
982.00
2,191.00
-1,209.00
-55.18%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
982.00
2,191.00
-1,209.00
-55.18%
Share in Profit of Associates
0
0
0.00
Minority Interest
56.00
33.00
23.00
69.70%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,038.00
2,224.00
-1,186.00
-53.33%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
66,857.00
86,051.00
-19,194.00
-22.31%
Earnings per share (EPS)
34.60
68.49
-33.89
-49.48%
Diluted Earnings per share
34.60
68.49
-33.89
-49.48%
Operating Profit Margin (Excl OI)
6.65%
15.38%
0.00
-8.73%
Gross Profit Margin
10.28%
40.01%
0.00
-29.73%
PAT Margin
5.58%
23.06%
0.00
-17.48%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,761.20 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -0.16% vs 24.12% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 9.94% vs 2.52% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 103.80 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -22.77% vs 34.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -19.35% vs -52.35% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 194.30 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -5.82% vs 380.89% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -10.00% vs 5.37% in Sep 2024

Quarterly - Interest
Interest 5.80 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 13.73% vs 218.75% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 427.27% vs 10.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.65%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024